. There were no demographic restrictions for the inclusion. All the patients were recruited from the Dermatology Service, Pius Hospital de Valls, Tarragona, Spain. Patients were randomly assigned to one of the two arms of the study (bleomycin alone and bleomycin combined with ECT). Of note, we did not test and stratify for HPV subtype the patients.
Therapeutic protocol
Each patient signed a consent form. Clinical and dermoscopic images of lesions were taken using a Canon PowerShot G11 (Canon, Inc, Tokyo, Japan) camera followed by shave biopsy. Affected areas were anesthetized with subcutaneous lidocaine; block anesthesia was not performed.
Overlying calluses were trimmed with a number 15 blade.
Bleomycin in a concentration of 1 mg/cm 3 was injected into verrucous foci at a depth of about 1.5 mm with a final volume of 0.1 cc. Patients enrolled in the arm including the ECT treatment, were subjected to trains of 8 biphasic pulses with an interpulse of 10 microseconds and a 50+50 microseconds duration, generated by an electroporator (Onkodisruptor®, Biopulse S.r.l., Naples, Italy). The pulses were delivered at a voltage of 700 V/cm, with 1 Hz frequency (total treatment
Introduction
Cutaneous warts are very common among dermatological diseases and are of benign nature. However, they can be extremely difficult to treat and can significantly impact quality of life [1, 2] . Human papillomavirus, a double-stranded DNA virus, is the etiologic agent of warts. The most common sites of infection are the hands, feet, face, and the anogenital area [3] . Several different therapeutic approaches are possible, depending on lesion size, number and location, patient age and comorbidities, as well as adverse reactions associated with therapy [4] . Numerous studies have been performed to evaluate the efficacy of intralesional bleomycin for the treatment of warts with inconsistent result [5] .
The uptake of this drug by the cells is slow and limited, because bleomycin can pass the cell membrane only through protein receptors due to its lipophobic nature [6] . In vitro studies, indeed, show evidence that less than 0.1% of bleomycin added to a culture medium becomes associated with the cell. Therefore, the high toxicity of bleomycin is weakened by its incapacity to freely diffuse through the cytoplasmic membrane [6] . Several studies have proved that the cytotoxicity of bleomycin can be enhanced in vivo by 300-to 700-fold by electroporation [7] . Electrochemotherapy (ECT)
is a loco-regional therapy that is based on the application of permeabilizing electric pulses on tumors or tumor beds after the administration (either systemic or intralesional) of a chemotherapy agent [6] . In veterinary medicine, ECT is currently adopted as first-line therapy, generally in an adjuvant fashion, to improve the chemotherapeutic agent uptake by the neoplastic cells, thus resulting in better local control of the neoplastic disease [7] . In humans, its use is actually focused on palliation of cutaneous metastases of melanoma [8] , but it is going to prove to be a valuable skin-directed therapy for a range of malignancies [9] . Among the numerous electroporation protocols implemented, our research group recently proposed a novel protocol involving the adoption of bursts of rectangular and biphasic pulses with a selected period of repetition [10] . This schedule enabled decreased morbidity of the treated animals and human beings as well as improving the clinical outcome [10] .
In this study, we investigate the potential benefits of combining intralesional bleomycin with ECT for the treatment of plantar warts of big dimensions, with respect to the treatment with bleomycin alone.
Material and Methods

Study Description
This study is an interventional, one-center, prospective case series, clinical trial on the effectiveness of intralesional bleomycin combined with ECT for the treatment of plantar warts, 
Statistical analysis
Fisher exact test was used to assess any difference in terms of response rate at the two time points between the control arm and the experimental arm. SPSS software (version 17.00, SPSS, Chicago) was used for statistical analysis. A P-value of less than 0.05 was considered to indicate statistical significance.
Results
Patient demographics
Characteristics of the patients enrolled in the protocol are depicted in Table 2 . Briefly, the study's cohort included 12 men and 10 women with ages ranging from 27 to 85 years, with a mean of 53.8 years. A total of 22 warts were treated, exclusively located on the feet. All patients were non-responders of other treatment modalities and had had a treatment history of more than 6 months. Table 2 summarizes the data obtained at 1 month and 3 months follow-up. Indeed, focusing on the 3-month followup, 78% (7/9) of patients treated with bleomycin coupled time: 1 ms per cm 2 of treated area). The pulses have been delivered by using caliper electrodes. In Figure 1 , panel A, an example of calipers application on a plantar wart is depicted.
Efficacy
A pain scale (0, no pain; 10, maximum pain) was passed on each patient to evaluate pain during the procedure.
Data collection
Follow-up of the progress of the treatment process was sched- 
Side effects
Not one of the patients had adverse sys- 
Discussion
Bleomycin has been successfully used for the treatment of recalcitrant warts [11] .
The most likely mechanism of action of this drug is the creation of unstable free radicals causing single-strand breaks and apoptosis [12] . Multiple bleomycin administration techniques have been studied with various success rates [11, 13] . However, several intralesional bleomycin injections are generally necessary to obtain clearance of the warts [14] . Concerning side effects, injection that the treatment of choice for warts remains ambiguous, despite the proved efficacy of intralesional bleomycin [15] .
Several studies have demonstrated that the efficacy of bleomycin can be greatly improved by coupling its injection with
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electrical pulses enabling the cells to be more prone to incorporate bleomycin [7] . Indeed, bleomycin is one of the most used drugs in ECT protocols for the treatment of tumors [8] .
A major goal of this project was to demonstrate an increased efficacy in the treatment of plantar warts with intralesional bleomycin coupled with electroporation. Indeed, the results of our study show that electroporation coupled with bleomycin significantly improve the outcome of patients with respect to the patients treated with bleomycin alone. Nevertheless, in our experimental protocol, only one intralesional injection of bleomycin was performed and, when coupled with electroporation, was sufficient to get complete remission in the majority of the patients with disappearance of the wart.
This further supports the idea that electroporation is able to amplify the effect of bleomycin, since its efficacy in the treatment of warts is generally linked to multiple injections on the site of the wart [15] . The second goal of the project was to demonstrate that the application of electric voltage to the warts had no adverse side effects. Indeed, none of the patients suffered systemic side effects, and the only local adverse effects were the pain at the site of the injection and occasionally redness and tenderness of the skin. Electroporation was well tolerated by the patients without any discomfort.
The main limitation of our study was the small number of patients enrolled in the protocol. Therefore, additional studies are necessary to confirm the efficacy of electroporation cou- H I
